AstraZeneca's lung cancer drug meets main goal in late-stage trial

July 18, 2016 6:45 AM

15 0

AstraZeneca's lung cancer drug meets main goal in late-stage trial

AstraZeneca Plc said its experimental lung cancer drug Tagrisso met its main goal in a late-stage study.

The tablet, which has won early approval from both U.S. and European regulators, is one of several cancer medicines AstraZeneca hopes will rebuild its sales following patent losses on older drugs.

Read more

To category page

Loading...